Cargando…

Tumor-specific activity of precision medicines in the NCI-MATCH trial

BACKGROUND: NCI-MATCH is a precision medicine basket trial designed to test the effectiveness of treating cancers based on specific genetic changes in patients’ tumors, regardless of cancer type. Multiple subprotocols have each tested different targeted therapies matched to specific genetic aberrati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Ivvone, Plana, Deborah, Palmer, Adam C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10081392/ https://www.ncbi.nlm.nih.gov/pubmed/37034644 http://dx.doi.org/10.1101/2023.03.30.23287951

Ejemplares similares

The New NCI Precision Medicine Trials
por: Harris, Lyndsay N., et al.
Publicado: (2023)

Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial
por: Mansfield, A. S., et al.
Publicado: (2022)

The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
por: Flaherty, Keith T, et al.
Publicado: (2020)

Precision Medicine in Osteosarcoma: MATCH Trial and Beyond
por: Tirtei, Elisa, et al.
Publicado: (2021)

Corrigendum to: The Molecular Analysis for Therapy Choice (NCI-MATCH) Trial: Lessons for Genomic Trial Design
Publicado: (2021)

Growth in eligibility criteria content and failure to accrue among National Cancer Institute (NCI)‐affiliated clinical trials
por: Peterson, John S., et al.
Publicado: (2022)

Independent Drug Action in Combination Therapy: Implications for Precision Oncology
por: Plana, Deborah, et al.
Publicado: (2022)

Cancer patient survival can be parametrized to improve trial precision and reveal time-dependent therapeutic effects
por: Plana, Deborah, et al.
Publicado: (2022)

Comparing the Efficacy of Cancer Therapies between Subgroups in Basket Trials
por: Palmer, Adam C., et al.
Publicado: (2020)

Overview and Utilization of the NCI Thesaurus
por: Fragoso, Gilberto, et al.
Publicado: (2004)

Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2
por: Wisinski, Kari B., et al.
Publicado: (2023)

NCI Imaging Data Commons
por: Fedorov, Andrey, et al.
Publicado: (2021)

Right data for right patient—a precisionFDA NCI–CPTAC Multi-omics Mislabeling Challenge
por: Boja, Emily, et al.
Publicado: (2018)

Enrollment of adolescent and young adult patients newly diagnosed with cancer in NCI CTEP‐sponsored clinical trials before and after launch of the NCI National Clinical Trials Network
por: Sankaran, Hari, et al.
Publicado: (2022)

MatchMiner: an open-source platform for cancer precision medicine
por: Klein, Harry, et al.
Publicado: (2022)

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
por: Johnson, J I, et al.
Publicado: (2001)

An anthropomorphic spine phantom for proton beam approval in NCI‐funded trials
por: Cho, Jongmin, et al.
Publicado: (2014)

İNTERNET 20'NCİ YAŞINI KUTLUYOR
Publicado: (2009)

İnternet 20`nci yaşını kutluyor
Publicado: (2009)

National Cancer Institute (NCI) Program for Natural Products Discovery: Rapid Isolation and Identification of Biologically Active Natural Products from the NCI Prefractionated Library
por: Grkovic, Tanja, et al.
Publicado: (2020)

Knockdown of neuron-specific enolase suppresses the proliferation and migration of NCI-H209 cells
por: Liu, Xia, et al.
Publicado: (2019)

HLA class I and II genotype of the NCI-60 cell lines
por: Adams, Sharon, et al.
Publicado: (2005)

Molecular Landscape and Actionable Alterations in a Genomically Guided Cancer Clinical Trial: National Cancer Institute Molecular Analysis for Therapy Choice (NCI-MATCH)
por: Flaherty, Keith T., et al.
Publicado: (2020)

On the Best Way to Cluster NCI-60 Molecules
por: Hernández-Hernández, Saiveth, et al.
Publicado: (2023)

Analysis of Pathway Activity in Primary Tumors and NCI60 Cell Lines Using Gene Expression Profiling Data
por: Feng, Xing-Dong, et al.
Publicado: (2007)

The fuzzy world of precision medicine: deliberations of a precision medicine tumor board
por: McGraw, Sarah A, et al.
Publicado: (2017)

Biomarkers in phase I–II chemoprevention trials: lessons from the NCI experience
por: Szabo, Eva
Publicado: (2015)

NIEHS, NCI, and NIA Colaborate on Breast Cancer
Publicado: (1995)

Concentration of endogenous estrogens and estrogen metabolites in the NCI-60 human tumor cell lines
por: Xu, Xia, et al.
Publicado: (2012)

NCI-CONNECT rare CNS tumor initiative: current progress and anticipated future impact
por: Mansouri, Alireza, et al.
Publicado: (2020)

P03.14. Cancer complementary and alternative medicine research among NCI’s cancer centers program and the integrative medicine programs: an inventory
por: Mikhail, I, et al.
Publicado: (2012)

Detecting Role Errors in the Gene Hierarchy of the NCI Thesaurus
por: Min, Hua, et al.
Publicado: (2008)

NCCAM/NCI Phase 1 Study of Mistletoe Extract and Gemcitabine in Patients with Advanced Solid Tumors
por: Mansky, Patrick J., et al.
Publicado: (2013)

NCI–Clinical Trial Accrual in a Community Network Affiliated with a Designated Cancer Center
por: Kim, Daniel J., et al.
Publicado: (2020)

Investigating potential disparities in clinical trial eligibility and enrollment at an NCI‐designated comprehensive cancer center
por: Patel, Monica A., et al.
Publicado: (2023)

National Cancer Institute (NCI) Program for Natural Product Discovery: Exploring NCI-60 Screening Data of Natural Product Samples with Artificial Neural Networks
por: Evans, Jason R., et al.
Publicado: (2023)

NIEHS Joins EPA and NCI in Agricultural Health Study
Publicado: (1993)

Integrated metabolome and transcriptome analysis of the NCI60 dataset
por: Su, Gang, et al.
Publicado: (2011)

Quantitative Proteome Landscape of the NCI-60 Cancer Cell Lines
por: Guo, Tiannan, et al.
Publicado: (2019)

2007 EORTC-NCI-ASCO Annual Meeting: Molecular Markers in Cancer
por: Lukan, C
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_fias0rcm7nj6k4sa8uhl84gu91